We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

30 Million Children Vaccinated by Global Agencies

By Biotechdaily staff writers
Posted on 30 Jul 2003
Five-year commitments to immunize children in the world's poorest countries have exceeded US$1 billion, according to the Global Alliance for Vaccines and Immunization (GAVI, Washington, DC, USA). Already, 30 million children have benefited from the nearly $250 million in new vaccines and infrastructure disbursed so far.

Including Angola, Chad, and Congo, which were recently approved for funding, 71 countries have received vaccines from The Vaccine Fund, the financing arm of GAVI. Many of these are showing impressive signs of success. Immunization rates in Mali and Uganda, for example, have reversed their falling coverage rate of the late 1990s and are now reaching even more children than they had anticipated in their original application. The agencies estimate that global immunization efforts will prevent as many as 300,000 deaths. Two out of every three nonimmunized children are in five countries: India, Nigeria, China, Pakistan, and Indonesia.

GAVI was created as a public/private partnership to reverse the decline in immunization coverage in developing countries during the 1990s and was launched with an initial grant from the Bill & Melinda Gates Foundation. Other participants include national governments, UNICEF, WHO, The World Bank, the vaccine industry, and public health organizations.

"As new vaccines become available and more children are born in developing countries, costs are soaring for The Vaccine Fund,” said Jacques-Francois Martin, president. "We urgently need to raise more money and bring new public and private donors to the table.”




Related Links:
Global Alliance for Vaccines and Immunization

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
30 Jul 2003  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
30 Jul 2003  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
30 Jul 2003  |   BioResearch